Log In
BCIQ
Print this Print this
 

DeciMab

  Manage Alerts
Collapse Summary General Information
Company DecImmune Therapeutics Inc.
DescriptionA humanized mAb which inhibits IgM binding and blocks N2-driven inflammatory cascade
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat vascular inflammatory diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today